Certified by Founder Lodge
Oryon Cell Therapies
United States - Belmont, Massachusetts
START UP
1 Disclosed Funding Rounds $21,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Oryon Cell Therapies is a clinical-stage biotechnology company developing autologous cell therapies for neurodegenerative disorders, with an initial focus on Parkinson’s disease. Co-founded i
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 24 ,2026 | Series A | $21,000,000 |
Byers Capital
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
XCENA | $135,000,000 | (Jun 2, 2026)
Voxmind | $735,203 | (Jun 2, 2026)
Human Archive (YC W26) | $8,200,000 | (Jun 2, 2026)
SpeedLabs | $6,500,000 | (Jun 2, 2026)
Invertix | $1,977,831 | (Jun 2, 2026)
